Targeted High-Intensity Exercise With And Without Osteoporosis Medications To Reduce Fracture Risk In Postmenopausal Women

被引：0
作者：
Kistler-Fischbacher, Melanie [1 ]
Yong, Jedidah S. [1 ]
Weeks, Benjamin K. [1 ]
Beck, Belinda R. [1 ]
机构：
[1] Griffith Univ, Gold Coast, Australia
来源：
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE | 2021年 / 53卷 / 08期
关键词：
D O I：
暂无
中图分类号：
G8 [体育];
学科分类号：
04 ; 0403 ;
摘要：
358
引用
收藏
页码：111 / 112
页数：2
相关论文
共 50 条
  • [41] Effect of Abaloparatide on Bone Mineral Density and Fracture Incidence in a Subset of Younger Postmenopausal Women with Osteoporosis at High Risk for Fracture
    Saag, Kenneth G.
    Williams, Setareh A.
    Wang, Yamei
    Weiss, Richard J.
    Cauley, Jane A.
    [J]. CLINICAL THERAPEUTICS, 2020, 42 (06) : 1099 - +
  • [42] A Comparison of Bone-Targeted Exercise With and Without Antiresorptive Bone Medication to Reduce Indices of Fracture Risk in Postmenopausal Women With Low Bone Mass: The MEDEX-OP Randomized Controlled Trial
    Kistler-Fischbacher, Melanie
    Yong, Jedidah S.
    Weeks, Benjamin K.
    Beck, Belinda R.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2021, 36 (09) : 1680 - 1693
  • [43] Is moderate- to high-intensity exercise safe for middle- and older-age women with osteoporosis or osteopenia?
    Chilibeck, Phil
    Hosseini, Zeinab
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 : 145 - 145
  • [44] Regular exercise may reduce risk of breast cancer in postmenopausal women
    不详
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (19): : 1430 - 1430
  • [45] Cost-effectiveness of romosozumab for the treatment of postmenopausal women with severe osteoporosis at high risk of fracture in Sweden
    E. Söreskog
    I. Lindberg
    J.A. Kanis
    K.E. Åkesson
    D. Willems
    M. Lorentzon
    O. Ström
    P. Berling
    F. Borgström
    [J]. Osteoporosis International, 2021, 32 : 585 - 594
  • [46] Cost-effectiveness of romosozumab for the treatment of postmenopausal women with severe osteoporosis at high risk of fracture in Sweden
    Soreskog, E.
    Lindberg, I.
    Kanis, J. A.
    Akesson, K. E.
    Willems, D.
    Lorentzon, M.
    Strom, O.
    Berling, P.
    Borgstrom, F.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2021, 32 (03) : 585 - 594
  • [47] Romosozumab for the treatment of postmenopausal women at high risk of fracture
    Geusens, Piet
    Appelman-Dijkstra, Natasha
    Lems, Willem
    van den Bergh, Joop
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (01) : 11 - 19
  • [48] Low self-awareness of osteoporosis and fracture risk among postmenopausal women
    Langer, Felipe Welter
    da Silveira Codevilla, Antonio Aurelio
    Dal Osto, Leo Canterle
    Sanchez Campos, Thabara Renaty
    Martins, Tamires Tolazzi
    Barin, Ana Elize
    Rigo, Pietro Hagamenon
    Boufleuer, Natalia Diel
    Santinon, Sheyla Fabiane
    Kipper, Kaira
    Rodrigues, Juliano
    Premaor, Melissa Orlandin
    [J]. ARCHIVES OF OSTEOPOROSIS, 2016, 11 (01)
  • [49] Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis
    Leder, Benjamin Z.
    Mitlak, Bruce
    Hu, Ming-Yi
    Hattersley, Gary
    Bockman, Richard S.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (03) : 938 - 943
  • [50] SUBCLINICAL HYPERTHYROIDISM AND HIGH FRACTURE RISK IN POSTMENOPAUSAL OSTEOPENIA AND OSTEOPOROSIS PATIENTS
    Pastore, Renato
    Borboni, Patrizia
    Chioma, Laura
    Vancieri, Giuseppe
    Frajese, Giovanni Vanni
    [J]. OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 387 - 387
12345